Fractyl Health, Inc. Sustainability Profile
Fractyl Health, Inc., headquartered in the United States, is a pioneering company in the healthcare industry, focusing on innovative solutions for metabolic diseases. Founded in 2010, Fractyl has made significant strides in developing therapies that address the underlying causes of type 2 diabetes and obesity, setting itself apart with its unique approach to metabolic health. The company’s flagship product, the Revita procedure, is a minimally invasive treatment designed to improve metabolic function and promote weight loss. This groundbreaking service has positioned Fractyl as a leader in the metabolic health sector, with a commitment to transforming patient outcomes through advanced medical technology. With a strong presence in major operational regions across the US, Fractyl Health continues to drive progress in metabolic disease management, earning recognition for its innovative contributions to the field.
DitchCarbon Score
How does Fractyl Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fractyl Health, Inc.'s score of 28 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fractyl Health, Inc.'s reported carbon emissions
Fractyl Health, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented reduction targets or climate commitments available from the company. As of now, Fractyl Health, Inc. does not inherit emissions data from any parent or related organisations, nor does it have any publicly stated initiatives or commitments towards carbon reduction. The lack of emissions reporting suggests that the company may still be in the early stages of developing its climate strategy or may not yet have formalised its sustainability goals. In the context of the industry, it is increasingly important for companies to establish clear climate commitments and reduction targets to align with global sustainability efforts.
How Carbon Intensive is Fractyl Health, Inc.'s Industry?
How Carbon Intensive is Fractyl Health, Inc.'s Location?
Fractyl Health, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fractyl Health, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
